Skip to content

MasterScreen Paed - Baby Body

by Viasys Healthcare GmbH

510(k) K081823

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK081823 Date18 May 2009ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
CCM
Device Class
Class II
Regulation
21 CFR Part 868.1750
Advisory Committee
Anesthesiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The MasterScreen Paed - Baby Body is a plethysmograph, pressure device designed for pediatric pulmonary function testing. It measures lung volumes and airway resistance in infants and young children, supporting the diagnosis and management of respiratory conditions by accommodating their unique physiological characteristics.

This device is intended for use in clinical settings, including anesthesiology, and is classified as a Class II medical device under FDA regulation 868.1750. It is supplied as a reusable instrument, with no explicit indication of sterility requirements in the available data. The device holds an FDA 510(k) clearance (K081823) under the Substantially Equivalent determination, approved in 2009.

Other devices from Viasys Healthcare GmbH

See all devices from Viasys Healthcare GmbH →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of respiratory conditions can the MasterScreen Paed - Baby Body help diagnose or monitor in infants and young children?

    The MasterScreen Paed - Baby Body is designed for pediatric pulmonary function testing, specifically measuring lung volumes and airway resistance in infants and young children. It supports the diagnosis and management of respiratory conditions by adapting to their unique physiological characteristics, though the exact conditions it aids in diagnosing are not specified in the data. Clinicians use it to assess conditions like asthma, bronchopulmonary dysplasia, or other obstructive/respiratory disorders in this age group.

  • Is the MasterScreen Paed - Baby Body intended for use in operating rooms or only clinical settings like pulmonary function labs?

    While the device is primarily intended for clinical settings, the data explicitly mentions its use in anesthesiology, meaning it is also suitable for operating rooms or procedural areas where pediatric respiratory assessments are required during anesthesia. Its design accommodates infants and young children, making it versatile for both diagnostic and intraoperative monitoring.

  • How is the MasterScreen Paed - Baby Body supplied, and does it require sterilization between uses?

    The device is supplied as a reusable instrument, meaning it is not single-use. The data does not specify explicit sterility requirements, so proper cleaning and disinfection protocols (as per facility guidelines) would apply to maintain safety between uses. Clinicians should follow manufacturer-recommended reprocessing instructions to ensure hygiene and functionality.

  • What regulatory pathway was followed for FDA clearance of the MasterScreen Paed - Baby Body, and when was it approved?

    The device received FDA clearance through a 510(k) submission (K081823), determined to be Substantially Equivalent (SESE) to a predicate device. The clearance was granted on May 18, 2009, under the Anesthesiology advisory committee review. This classification aligns with its use in pediatric pulmonary function testing and anesthesia-related settings.